IDEXX Laboratories Inc (IDXX)
489.24
-5.02
(-1.02%)
USD |
NASDAQ |
Apr 25, 16:00
489.28
+0.04
(+0.01%)
After-Hours: 20:00
IDEXX Laboratories Gross Profit Margin (Quarterly): 58.36% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 58.36% |
September 30, 2023 | 59.85% |
June 30, 2023 | 60.71% |
March 31, 2023 | 60.32% |
December 31, 2022 | 58.53% |
September 30, 2022 | 60.19% |
June 30, 2022 | 59.73% |
March 31, 2022 | 59.62% |
December 31, 2021 | 56.98% |
September 30, 2021 | 58.36% |
June 30, 2021 | 59.23% |
March 31, 2021 | 60.53% |
December 31, 2020 | 56.80% |
September 30, 2020 | 58.55% |
June 30, 2020 | 59.50% |
March 31, 2020 | 57.41% |
December 31, 2019 | 54.70% |
September 30, 2019 | 56.99% |
June 30, 2019 | 57.71% |
March 31, 2019 | 57.56% |
December 31, 2018 | 54.67% |
September 30, 2018 | 56.04% |
June 30, 2018 | 57.24% |
March 31, 2018 | 56.37% |
December 31, 2017 | 53.84% |
Date | Value |
---|---|
September 30, 2017 | 55.69% |
June 30, 2017 | 57.51% |
March 31, 2017 | 55.88% |
December 31, 2016 | 54.32% |
September 30, 2016 | 55.04% |
June 30, 2016 | 55.84% |
March 31, 2016 | 54.49% |
December 31, 2015 | 54.47% |
September 30, 2015 | 55.19% |
June 30, 2015 | 56.31% |
March 31, 2015 | 56.35% |
December 31, 2014 | 51.76% |
September 30, 2014 | 55.63% |
June 30, 2014 | 56.01% |
March 31, 2014 | 56.11% |
December 31, 2013 | 53.28% |
September 30, 2013 | 54.92% |
June 30, 2013 | 56.07% |
March 31, 2013 | 55.40% |
December 31, 2012 | 52.90% |
September 30, 2012 | 54.09% |
June 30, 2012 | 55.02% |
March 31, 2012 | 54.16% |
December 31, 2011 | 51.72% |
September 30, 2011 | 52.72% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
54.70%
Minimum
Dec 2019
60.71%
Maximum
Jun 2023
58.63%
Average
58.55%
Median
Sep 2020
Gross Profit Margin (Quarterly) Benchmarks
Stryker Corp | 63.68% |
Haemonetics Corp | 52.90% |
Align Technology Inc | 69.98% |
Edwards Lifesciences Corp | 76.74% |
ACADIA Pharmaceuticals Inc | 92.26% |
Gross Profit Margin (Quarterly) Related Metrics
Return on Equity | 79.34% |
Return on Assets | 28.60% |
Return on Invested Capital | 38.84% |
Profit Margin (Quarterly) | 21.58% |
Operating Margin (Quarterly) | 27.21% |
Return on Net Operating Assets | 38.48% |